✦ LIBER ✦

494 Phase II study of S-1 in combination with irinotecan (CPT-11) for patients with advanced/recurrent breast cancer (KSCOG-BC01)

✍ Scribed by U. Toh; T. Fukushima; M. Fukunaga; N. Iwakuma; M. Takenaka; H. Otsuka; K. Shirouzu; E. Ogo

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I study of combination therapy w

✍ Manabu Shiozawa; Nobuhiro Sugano; Kazuhito Tsuchida; Soichiro Morinaga; Makoto A 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 296 KB

Health-related quality of life in patien

✍ Akira Tsunoda; Naokuni Yasuda; Kentaro Nakao; Kazuhiro Narita; Makoto Watanabe; 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 175 KB

A phase II study of combination therapy

✍ Manabu Shiozawa; Makoto Akaike; Nobuhiro Sugano; Kazuhito Tsuchida; Naoto Yamamo 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 347 KB

A phase II study of UCN-01 in combinatio

✍ Cynthia X. Ma, Matthew J. C. Ellis, Gina R. Petroni, Zhanfang Guo, Shi-rong Cai, 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 466 KB

Phase II study of combined chemotherapy

✍ Komatsu, Yoshito; Yuki, Satoshi; Sogabe, Susumu; Fukushima, Hiraku; Nakatsumi, H 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 104 KB

Phase I–II study of irinotecan (CPT-11)

✍ Tsuda, H; Hashiguchi, Y; Nishimura, S; Miyama, M; Nakata, S; Kawamura, N; Negoro 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 101 KB